RecruitingPhase 2 / Phase 3NCT05076175
A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
Sponsor: Bristol-Myers Squibb
Iowa City, IA · +35 more sites
2 recruiting ulcerative colitis studies with a site in Iowa City, IA.
Sponsor: Bristol-Myers Squibb
Iowa City, IA · +35 more sites
Sponsor: University of North Carolina, Chapel Hill
Iowa City, IA · +10 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.